BFRI · Biofrontera Inc. · Documents

$0.83 +0.02 (+2.50%) At close · Nov 6 Play latest call Q1 2026 earnings call transcript

Market Cap

$12.30M

14.85M

Volume · Nov 6 209.3K Avg daily vol (3M) 490.11K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022

Aug 12

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $4.46M ▼ 23.9% Net loss $850K Diluted EPS -$0.05

Jul 28

Current report 8-K Events of Jul 27

Entered into a material agreement, Unregistered sale of equity, Change to shareholders' rights, Other events

Jul 12

Current report 8-K

Financial results

Jun 7

Registration statement S-1

Registration statement

May 24

Current report 8-K/A Events of Mar 2

Director or officer change, or executive pay

May 24

Current report 8-K Events of May 18

Director or officer change, or executive pay, Other events

May 20

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Other events

May 13

Earnings call

Q1 2022 earnings call

May 13

Current report 8-K

Financial results

May 13

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $9.75M ▲ 105.5% Net income $5.56M Diluted EPS $0.32

Apr 11

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $24.1M ▲ 27.9% Net loss $37.71M

Apr 8

Current report 8-K

Financial results

Apr 6

Current report 8-K

Financial results

Apr 5

Current report 8-K Events of Mar 31

Entered into a material agreement, Director or officer change, or executive pay

Apr 1

Late filing notice NT 10-K

Late filing notice

Mar 8

Current report 8-K Events of Mar 2

Director or officer change, or executive pay

Jan 18

Earnings call

Q4 2021 earnings call

Jan 13

Current report 8-K

Financial results

2021

Dec 29

Current report 8-K Events of Dec 28

Other events

Dec 21

Registration statement S-1

Registration statement

Dec 3

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Other events

Nov 30

Earnings call

Q3 2021 earnings call

Nov 30

Current report 8-K

Financial results

Nov 30

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $4.33M ▲ 33.3% Net loss $16.01M

Nov 29

Current report 8-K

Regulation FD disclosure

Nov 3

Current report 8-K

Entered into a material agreement, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events

Oct 26

Registration statement S-1/A

Registration statement

Oct 19

Registration statement S-1/A

Registration statement

Oct 15

Registration statement S-1/A

Registration statement

Oct 14

Registration statement S-1/A

Registration statement

Oct 13

Registration statement S-1/A

Registration statement

Oct 12

Registration statement S-1/A

Registration statement

Oct 1

Registration statement S-1/A

Registration statement

Sep 16

Registration statement S-1/A

Registration statement

Aug 31

Registration statement S-1/A

Registration statement

Aug 12

Registration statement S-1/A

Registration statement

Jul 26

Registration statement S-1/A

Registration statement

Jul 6

Registration statement S-1

Registration statement

Showing 151–188 of 188 documents

Key facts CIK 1858685 CUSIP 09077D209 13F (30d) 5 filings 5 filers Visit website Investor relations